Myosin Therapeutics
FL - JupiterBiotechnology
Focus: Myosin Therapeutics is an early-stage biotech focused on novel medications targeting cellular motor proteins for oncology indications. The company is pre-revenue with a single Phase 1 program and operates from Jupiter, Florida.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Open Jobs
0
About Myosin Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Myosin Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MT-125
Glioblastoma (GBM)Clinical Trials (1)
NCT07185880A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Phase 1/2Help build intelligence for Myosin Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.